Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.9800 (-3.39%) ($9.9800 - $9.9800) on Thu. Feb. 9, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.96% (three month average) | RSI | 72 | Latest Price | $9.9800(-3.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.5% a day on average for past five trading days. | Weekly Trend | EDIT advances 11.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(69%) IBB(56%) IWC(52%) IWO(49%) IWM(48%) | Factors Impacting EDIT price | EDIT will decline at least -2.48% in a week (0% probabilities). VIXM(-15%) SMH(-9%) IGOV(-8%) UUP(-6%) TBT(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.48% (StdDev 4.96%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $10.81(-7.68%) | 10 Day Moving Average | $10.5(-4.95%) | 20 Day Moving Average | $9.53(4.72%) | To recent high | -24.6% | To recent low | 27.8% | Market Cap | $620m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |